Research and experimental development on natural sciences and engineering
ALDEN CANCER THERAPY AS
Operating profit
NOK −1.9m
Equity
NOK −2.8m
Incorporated
2013
Share capital
NOK 47,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating costs | 1.9m | |
| Operating profit (EBIT) | −1.9m | |
| Net financial items | 9k | |
| Profit for the year | −1.9m |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 1.8m | |
| of which current assets | 1.2m | |
| Equity | −2.8m | |
| Total liabilities | 4.5m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.